Strand Life Sciences provides Bioinformatics Solutions based on advanced visualization, predictive systems modeling, data integration and scientific context management components to transform raw data into actionable insights. The company employs 200 people, mostly in Bangalore, India, and is offering both clinical and research markets. When combined, Strand is meeting a rapidly increasing demand for its StrandOmics software platform that hospitals and service providers can use to serve their patients and healthcare clients. With every sequence and gene test, the company's cloud database is gained with related metadata that can be used to improve future analytics, creating an additional demand for StrandOmics. Strand has developed the most advanced software for the analysis of DNA sequences. Today, 1,400 research institutions use Strand's software under the product names GeneSpring and Avadis. In 2007 the company reached profitability and in early 2013 began to service the clinical market in India. In December it opened its own DNA sequence and a gene panel wet lab in Bangalore, India and closed a lab it operates in the 1,400-bed Mazumdar-Shaw Cancer Center in Bangalore. By the end of 2013, Strand was supporting the needs of over 100 hospitals in India in gene testing and DNA sequence analysis, and in 2014 it began to expand into the US market.
Legal Address
University Of Agricultural Sciences, Convention -Centre Veterinary College Campus, Bellary Road,
Bangalore; Karnataka;
Postal Code: 560024
Contact Details: Purchase the Strand Life Sciences Private Limited report to view the information.
Website: https://strandls.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service